Celltrio designs and manufactures scalable cell culture automation platforms that integrate seamlessly into R&D and GMP environments. Its flagship RoboCell® system fully automates processes in sterile cell culturing, and cell and gene therapy, delivering high-throughput, consistent results for biopharma, cell therapy, and regenerative medicine labs.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/17/25 | $15,000,000 | Venture |
Premier Partners | undisclosed |
